Fed Circuit resuscitates heart monitoring patent

The US Court of Appeals for the Federal Circuit has overturned a lower court’s decision to find a heart monitoring patent invalid under Alice, handing a win to medical laboratory company BioTelemetry.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

SCOTUS won’t resuscitate heart monitor patent case

26 January 2021 In a win for medical laboratory BioTelemetry, the US Supreme Court has refused to review a court ruling that revived a cardiac monitoring patent.

Americas

Fed Circ grants Arthrex remand, rejects Iancu conflict

10 September 2020 The US Court of Appeals for the Federal Circuit granted the owner of an artificial heart valve patent a remand under Arthrex, but shot down the company’s attempt to escape an inter partes review by citing a conflict.

Americas

Federal Circuit remands Abbott drug test patent suit

14 April 2020 The US Court of Appeals for the Federal Circuit has ordered a new trial in a patent dispute between Abbott-subsidiary Alere and patent monetisation company Rembrandt Diagnostics.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Fed Circuit resuscitates heart monitoring patent

More on this story

Editor's picks

Editor's picks

More features